661. Health-related quality of life impairment is equal for antiphospholipid syndrome whether primary or associated with systemic lupus erythematosus.
作者: Ewa Haladyj.;Agata Matusiewicz.;Tomasz Wysocki.;Marzena Olesinska.
来源: Reumatologia. 2024年62卷4期266-273页
Antiphospholipid syndrome (APS) manifests with thrombosis and pregnancy losses and may significantly impair the health-related quality of life (HRQoL). So far, APS has been perceived as a less burdensome disease than systemic lupus erythematosus (SLE), but data on this are scarce. The purpose of the present study was to evaluate HRQoL in APS patients by applying the Short Form 36 Health Survey (SF-36) and World Health Organization Quality-of-Life Scale (WHOQoL-BREF); to examine the impact of primary APS and with coexisting SLE (APS/SLE) on patient HRQoL; and to provide a description of the APS patient population.
662. Non-traumatic spinal cord injury - etiological profile and associated factors: single rheumatological center experience.
作者: Yannick L T Bayala.;Ismael Ayouba Tinni.;Fulgence Kaboré.;Aboubakar Ouédraogo.;Enselme Y Zongo.;Marcellin Bonkoungou.;Joëlle Wendlassida Stéphanie Zabsonré-Tiendrebeogo.;Dieu-Donné Ouédraogo.
来源: Reumatologia. 2024年62卷4期259-265页
Non-traumatic spinal cord injury (NTSCI) represents a medical-surgical emergency. In Burkina Faso, limited data exist on the etiological profiles of this syndrome in rheumatology. This study aimed to describe the etiological profile of NTSCI in the Rheumatology Department of the University Hospital Center of Bogodogo (CHU-B).
663. The kynurenine pathway in patients with rheumatoid arthritis during tumor necrosis factor α inhibitors treatment.
作者: Joanna Witoszyńska-Sobkowiak.;Dorota Sikorska.;Karolina Niklas.;Iwona Żychowska.;Rafał Rutkowski.;Włodzimierz Samborski.
来源: Reumatologia. 2024年62卷4期220-225页
The importance of the kynurenine pathway in normal immune system function has led to an appreciation of its possible contribution to autoimmune disorders such as rheumatoid arthritis (RA). The aim of the study was to evaluate the effect of treatment with tumor necrosis factor α (TNF-α) inhibitors on the activity of the kynurenine pathway in patients with RA.
665. Rheumatological manifestations of H syndrome.
作者: Rahma Honsali.;Latifa Tahiri.;Sara Cherkaoui-Dekkaki.;Fadoua Allali.
来源: Reumatologia. 2024年62卷4期294-303页
H syndrome (HS) is a rare autosomal recessive genodermatosis characterised by cutaneous hyperpigmentation, hypertrichosis, sclerodermatous thickening, and multisystemic involvement. It results from mutations in the SLC29A3 gene encoding the human equilibrative nucleoside transporter 3, leading to impaired histiocyte apoptosis and unchecked proliferation. We report the case of a 24-year-old Moroccan male who had a history of insulin-dependent diabetes mellitus. He developed hyperpigmented skin patches with hypertrichosis and induration. Musculoskeletal findings included bilateral hallux valgus, pes planus, reducible flexion contractures of the proximal interphalangeal joints, and restricted ankle dorsiflexion. Additional findings consist of lymphadenopathy, hepatomegaly, hypogonadism, and ophthalmic manifestations. Investigations showed elevated sedimentation rate, anaemia, and osteopaenia. Ankle ultrasound revealed calcaneal enthesopathy and subcutaneous infiltration. In reporting this case, we aim to highlight the significant rheumatological involvement that can arise in patients with H syndrome and explore potential treatment options to improve the musculoskeletal findings.
666. Clinical and laboratory pattern of patients with systemic lupus erythematosus seropositive for rheumatoid factor.
作者: Oleg Iaremenko.;Galyna Protsenko.;Vitalii Dubas.;Daria Koliadenko.
来源: Reumatologia. 2024年62卷4期226-234页
The aim of the study was to investigate the associations between the presence and level of rheumatoid factor (RF) in the blood serum and the clinical and laboratory characteristics of patients with systemic lupus erythematosus (SLE).
667. Musculoskeletal involvement in systemic sclerosis.
Systemic sclerosis (SSc) is a multi-organ, systemic connective tissue disease, which affects the lungs, heart, gastrointestinal tract, kidneys, skin, and musculoskeletal system. Musculoskeletal involvement is observed in 40-90% of patients with SSc. During the disease, any structure of the musculoskeletal system, such as bones, joints, tendon sheaths, tendons, and muscles, may be affected. The most common symptoms include joint pain, arthritis, tendinitis leading to tendon rupture, acro-osteolysis, calcinosis, myalgia, and myositis. Osteo-articular complications and changes in the soft tissues of the hand lead to finger contracture, which causes deterioration of the patients' quality of life and disability. To sum up, a more detailed understanding of the aetiology leading to progressive changes in the musculoskeletal system may contribute to the introduction of new therapeutic options, and thus improve the quality of life and reduce disability in patients with SSc.
668. Radiological measurement of posterior tibial subluxation as a preoperative factor in choosing the type of implant in primary total knee arthroplasty.
作者: Dawid Jegierski.;Bartosz Michał Maciąg.;Krystian Żarnovsky.;Tomasz Kordyaczny.;Maciej Świercz.;Grzegorz Jan Maciąg.;Artur Stolarczyk.
来源: Reumatologia. 2024年62卷4期235-241页
Total knee arthroplasty (TKA) is the most effective treatment of late osteoarthritis (OA) and is considered among the most successful surgical procedures in general. However, about 20% of patients remain dissatisfied. An important aspect of TKA is the proper choice of implant type - posterior stabilized (PS) or cruciate retaining (CR). Both have their indications for use based on intraoperative functional examination, but no objective radiological criteria have yet been developed. The aim of this study was to investigate the relationship between the posterior subluxation of the tibia on preoperative radiograms and implant type used.
669. Environmental pollution impact on the severity of some rheumatic diseases: a comparative analytical study on inflammatory and non-inflammatory samples.
Environmental pollution of heavy metals is increasingly a problem and has become of great concern due to the adverse effects it causes worldwide. Heavy metal exposure has been implicated in health problems, including fibromyalgia and rheumatoid arthritis. We aim to evaluate the rule of chronic heavy metals toxicity on the induction of vitamin D3 (VD) deficiency and parathyroid hormone (PTH) disturbances in an inflammatory disease like rheumatoid arthritis (RA) and non-inflammatory disease like fibromyalgia syndrome (FMS).
670. Demographics and clinical features associated with abnormal small bowel motility in systemic sclerosis.
作者: Jenice X Cheah.;Jamie Perin.;Michael Hughes.;Christopher A Mecoli.;Julie J Paik.;Laura K Hummers.;Ami A Shah.;Zsuzsanna H McMahan.
来源: Rheumatology (Oxford). 2025年64卷5期2775-2782页
The small bowel is affected in up to 50% of systemic sclerosis (SSc) patients, and some patients experience severe complications. Our aim was to use specific statistical methods to compare demographic and clinical features of SSc patients with and without abnormal small bowel to better characterize patients at risk for this complication.
671. The potential role of fatigue in difficult-to-treat rheumatoid arthritis.
作者: Leticia Leon.;Dalifer Freites-Núñez.;Alfredo Madrid.;María Rodriguez-Mariblanca.;Benjamín Fernandez-Gutierrez.;Lydia Abasolo.
来源: BMC Rheumatol. 2024年8卷1期49页
A subset of patients with rheumatoid arthritis (RA) who remains symptomatic after failing to multiple drugs are deemed to have "difficult-to-treat RA" (D2T RA). Fatigue is a burdensome symptom for RA patients, hindering their improvement. Our purpose was to evaluate the role of fatigue in D2T RA.
672. Menopausal state and rheumatoid arthritis: a systematic review and meta-analysis.
作者: Negin Namavari.;Mohammad Jokar.;Arnoosh Ghodsian.;Hossein Kargar Jahromi.;Vahid Rahmanian.
来源: BMC Rheumatol. 2024年8卷1期48页
Rheumatoid arthritis (RA) is a chronic inflammatory condition primarily affecting the joints. The higher prevalence of RA among females, combined with the known effects of sex hormones on immune function, has led researchers to investigate the potential relationship between menopausal status and the risk, severity, or progression of RA. This systematic review and meta-analysis aimed to determine the association between menopause and rheumatoid arthritis.
674. Systemic inflammation in asymptomatic hyperuricaemia with sonographic crystal deposits, including a comparison with normouricaemia and gout.
作者: María-Luisa Peral-Garrido.;Silvia Gómez-Sabater.;Rocío Caño.;Alejandra Bermúdez-García.;Paula Boix.;Teresa Lozano.;Ruth Sánchez-Ortiga.;Miguel Perdiguero.;Elena Caro-Martínez.;Carolina Ruiz-García.;Rubén Francés.;Eliseo Pascual.;Mariano Andrés.
来源: Rheumatology (Oxford). 2025年64卷4期1807-1816页
To describe the inflammatory profile of asymptomatic hyperuricaemia (AH) with ultrasound evidence of monosodium urate (MSU) crystals (AH-MSUpos), vs AH without deposits (AH-MSUneg), intercritical gout and normouricaemia.
675. Real-world outcomes of a dedicated fast-track polymyalgia rheumatica clinic.
作者: Sharon Cowley.;Patricia Harkins.;Colm Kirby.;Richard Conway.;David Kane.
来源: Rheumatology (Oxford). 2025年64卷5期3006-3011页
To examine the clinical impact of a fast-track PMR clinic to enable early diagnosis and treatment, and to define both patient and disease characteristics in newly diagnosed PMR.
676. Long-term retention rate, adverse event temporal patterns and rescue treatment strategies of mycophenolate mofetil in systemic sclerosis: insights from real-life.
作者: Enrico De Lorenzis.;Gerlando Natalello.;Greta Pellegrino.;Lucrezia Verardi.;Veronica Batani.;Gemma Lepri.;Stefano Stano.;Giuseppe Armentano.;Marco De Pinto.;Francesca Motta.;Stefano Di Donato.;Vishal Kakkar.;Silvia Fiore.;Ilaria Bisconti.;Corrado Campochiaro.;Laura Cometi.;Antonio Tonutti.;Amalia Spinella.;Simona Truglia.;Silvia Cavalli.;Maria De Santis.;Dilia Giuggioli.;Nicoletta Del Papa.;Serena Guiducci.;Fabio Cacciapaglia.;Giacomo De Luca.;Fiorenzo Iannone.;Valeria Ricceri.;Marco Matucci Cerinic.;Maria Antonietta D'Agostino.;Francesco Del Galdo.;Silvia Laura Bosello.
来源: Rheumatology (Oxford). 2025年64卷4期1966-1974页
MMF is a mainstay for the treatment of SSc. The occurrence and implications of MMF-related adverse events (AEs) on drug retention rates in real life remain poorly defined. We aimed to determine the MMF retention rate and to investigate the causes and patterns of discontinuation, AEs and treatment options used after discontinuation.
677. Incidence of serious infection among etanercept and infliximab initiators: safety comparison between biosimilars and bio-originators with Canadian population-based data.
作者: Marina G Birck.;Luck Lukusa.;Denis Choquette.;Gilles Boire.;Walter P Maksymowych.;Harminder Singh.;Waqqas Afif.;Sasha Bernatsky.
来源: BMC Rheumatol. 2024年8卷1期47页
Safety remains a significant concern for biologic drugs, and studies are needed to ensure a comparable safety profile for biosimilars and their legacy treatments. Using Canadian administrative health data from 2015-2019, we compared the incidence of serious infection between biosimilars and bio-originators initiators for etanercept and infliximab, two of the most commonly used biologics during this time.
678. Anti-pentraxin 3 antibodies and residual disease activity in rheumatoid arthritis.
作者: Mariangela Salvato.;Francesca Frizzera.;Anna Ghirardello.;Antonia Calligaro.;Costantino Botsios.;Margherita Zen.;Andrea Doria.;Alessandro Giollo.
来源: Rheumatology (Oxford). 2025年64卷4期1672-1678页
This study quantified anti-PTX3 antibodies in the serum of seropositive and seronegative RA patients, examining their associations with disease activity and patient-reported outcome measures (PROMs).
679. Efficacy and safety of filgotinib in patients with moderately active rheumatoid arthritis and an inadequate response to methotrexate.
作者: Maya H Buch.;David Walker.;Christopher J Edwards.;Jane Barry.;Laura Akroyd.;Edmund V Ekoka Omoruyi.;Peter C Taylor.
来源: Rheumatology (Oxford). 2025年64卷4期1661-1671页
Clinical trials restricted to moderately active RA are limited. Filgotinib is approved for treating moderate to severe active RA. This post hoc analysis assessed the efficacy and safety of filgotinib in moderately active RA.
680. A case of anti-CD320 antibody-positive cutaneous arteritis accompanied by multiple cranial nerve symptoms.
作者: Akiko Hasegawa.;Kazuki M Matsuda.;Hirohito Kotani.;Ai Kuzumi.;Asako Yoshizaki-Ogawa.;Ayumi Yoshizaki.;Shinichi Sato.
来源: Rheumatology (Oxford). 2025年64卷4期2309-2311页 |